# Relating proton LETd to biological response of parotid and submandibular glands using PSMA-PET in clinical patients

**Authors:** Dirk Wagenaar, Vineet Mohan, Johannes A. Langendijk, Roel J.H.M. Steenbakkers, Wouter V. Vogel, Stefan Both

PMC · DOI: 10.1016/j.ctro.2024.100910 · Clinical and Translational Radiation Oncology · 2025-01-09

## TL;DR

This study explores how proton radiation affects salivary glands in cancer patients using PSMA-PET scans, finding limited evidence for increased biological effects with higher LETd.

## Contribution

The study introduces a novel approach to derive a proton RBE model from PSMA-PET uptake in salivary glands after proton therapy.

## Key findings

- The average RBE-LET slope was 0.075 (keV/μm)-1 for parotid and submandibular glands combined.
- No clear evidence of increased RBE with higher LETd was found in parotid glands.
- A larger cohort and longer follow-up scans are needed to clarify the RBE-LET relationship.

## Abstract

•PSMA-PET uptake decrease after treatment in parotid glands relates to radiation dose.•The role of LETd in PSMA-PET uptake decrease was studied.•The role of LETd in parotid glands might be smaller than predicted by preclinical experiments.•A larger cohort scanned at later time intervals could be used to shed more light on this issue.

PSMA-PET uptake decrease after treatment in parotid glands relates to radiation dose.

The role of LETd in PSMA-PET uptake decrease was studied.

The role of LETd in parotid glands might be smaller than predicted by preclinical experiments.

A larger cohort scanned at later time intervals could be used to shed more light on this issue.

A recent study investigated the use of PSMA-PET in monitoring loss of secretory cells in salivary glands of head and neck cancer (HNC) patients. Previously, a dose–effect relation has been formulated to the PSMA-PET uptake in salivary glands. The aim of this study was to derive a proton RBE model from the PSMA-PET uptake in salivary glands after proton therapy of HNC patients.

Six patients treated with proton therapy were included. These patients received a PET-CT scan using 68Ga (N = 1) or 18F (N = 5) PSMA before treatment (baseline) and one month after the last fraction (follow-up). Physical dose (D), D·LETd and the follow-up PSMA-PET scan were deformed to the baseline PET-CT using deformable image registration. Parotid and submandibular gland delineations were adjusted to include voxels which had an uptake of ≥ 5 g/ml in the baseline PSMA-PET scan.

The average RBE-LET slope was 0.075 [0.009; 0.125] (keV/μm)-1 (mean [95 %CI]) for parotid and submandibular glands combined. When analyzing parotid or submandibular glands separately the RBE-LET curve slope varies with two and five patients showing a positive RBE-LET slope when only analyzing parotid or submandibular glands respectively.

Our study did not find clear evidence of an increased RBE in parotid and submandibular glands with increasing LETd. On average an LETd effect was observed, however our sample size was too small to clearly define an RBE-LET relation. A larger cohort scanned at later time intervals could shed more light on this issue.

## Linked entities

- **Diseases:** head and neck cancer (MONDO:0005627)

## Full-text entities

- **Genes:** FOLH1 (folate hydrolase 1) [NCBI Gene 2346] {aka FGCP, FOLH, GCP2, GCPII, NAALAD1, PSM}
- **Diseases:** HNC (MESH:D006258)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11803207/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11803207/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC11803207/full.md

---
Source: https://tomesphere.com/paper/PMC11803207